Clinical Trials Search Results

Results 41-50 of 281 for your search
Show Search Criteria
Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 4 locations
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
Status: Active
Age: 1 to 25 years
Gender: Male or Female
Location: 10 locations
9-ING-41 in Patients With Advanced Cancers
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 4 locations
P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 6 locations
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 5 locations
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 4 locations
Sapanisertib in Treating Patients with Newly Diagnosed or Refractory / Metastatic Anaplastic Thyroid Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 4 locations
A Dose Escalation Study Evaluating CPI-818 in Relapsed / Refractory T-Cell Lymphoma
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 6 locations
Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 6 locations
< Previous 1 2 3 4 5 6 7 ... 29 Next >